Beyond Air, Inc. Available-for-sale Securities, Equity Securities
Beyond Air, Inc. (XAIR) had Available-for-sale Securities, Equity Securities of $10.20 million as of 2019-12-31, per its 10-Q filed 2020-02-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesEquitySecurities · last filed 2020-11-12
- 2019-12-31: Available-for-sale Securities, Equity Securities $10.20M.
- 2019-07-02: Available-for-sale Securities, Equity Securities $100.00M.
| Period end | Available-for-sale Securities, Equity Securities |
|---|---|
| 2019-12-31 | $10.20M 10-Q · filed 2020-02-07 |
| 2019-07-02 | $100.00M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |